Introduction
============

The triptans, serotonin receptor B/D agonists, are the mainstay in the acute treatment of migraine\[[@B1]\]. Sumatriptan, the first triptan, was originally developed as a cranial vasoconstrictor by acting on the 5-HT1B/1D receptors in cephalic vessels\[[@B2]\]. However, several modes of action as well as multiple sites of action have been proposed.\[[@B3]\]

Objectives
==========

To explore a possible differential effect of sumatriptan on extra- versus intracerebral arteries, we examined the superficial temporal (STA), middle meningeal (MMA), extracranial internal carotid (ICAextra), intracranial internal carotid (ICAintra), middle cerebral (MCA) and basilar artery (BA).

Methods
=======

The arterial circumference were recorded by high resolution magnetic resonance angiography before and after subcutaneous sumatriptan injection (6 mg) in 18 healthy volunteers.

Results
=======

We found significant constrictions of MMA (16.5%), STA (16.4%), ICAextra (15.2%), MCA (5.5%) and BA (2.1%) (p ≤ 0.012). ICAintra changed by 1.8% (p = 0.179). Analyses of the relative changes between the intracerebral and extracerebral arteries revealed significantly larger constriction of the extracerebral than of the intracerebral (MCA, BA, ICAintra) arteries (p \< 0.000001).

Conclusion
==========

Sumatriptan constricts more extracerebral than intracerebral arteries. We suggest that sumatriptan exerts its anti-migraine action outside the blood-brain barrier by constricting the extracerebral arteries and blocking the nociceptive inputs from sensory afferents.
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